If you are:
Possibly Safe: INSUFFICIENT HUMAN DATA; NO EVIDENCE OF TERATOGENICITY IN RAT AND RABBIT STUDIES
Only When Necessary: FDA C W/COMBO PROD; POSS RISK OF GASTROSCHISIS/SIA WITH 1ST TRIMESTER EXPOSURE
Precaution: INSUFFICIENT DATA AVAILABLE
Precaution: MAY DECREASE MILK SUPPLY, AND CAUSE IRRITABILITY
An adult over 60:
management or monitoring precaution: Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
Giving acrivastine-pseudoephedrine capsule to a child under 12:
Contraindication: Increased sensitivity to side effects. Dose form or strength not appropriate.